U.S. needs more baby formula makers, Biden tells manufacturers
Send a link to a friend
[June 02, 2022]
By Trevor Hunnicutt and Jarrett Renshaw
(Reuters) -U.S. President Joe Biden met
with major infant formula manufacturers on Wednesday, and suggested
their ranks should grow, as his administration presses ahead with
efforts to boost imported supplies to help ease a nationwide
shortage."We need more new entrants in the infant formula market," Biden
said during a virtual meeting with executives from ByHeart, Bubs
Australia, Reckitt Benckiser Group, Perrigo Company and Nestle SA's
Gerber.
Multiple global suppliers are seeking U.S. approval to ship critical
baby formula as Biden's administration accelerates what it has dubbed
"Operation Fly Formula" to help fill store shelves and calm frustrated
parents.
The approximately $4 billion annual sales U.S. baby formula market has
historically been dominated by domestic producers, with imports limited
and subject to high tariffs.
But U.S. parents have struggled to find baby formula in recent months
after a February recall of some formulas by one of the nation's main
manufacturers, Abbott Laboratories, coupled with pandemic-related supply
chain issues.
The latest administration effort to solve the problem includes an
announcement on Wednesday that United Airlines has agreed to transport
U.K.-made Kendamil formula free of charge from Heathrow Airport in
London to multiple airports across the United States over a three-week
period.
This first shipment, which includes Kendamil Classic and Kendamil
Organic formula, will be available at Target stores across the country
in the coming weeks.
The administration also secured two flights totaling 380,000 pounds of
baby formula from Bubs Australia that will be delivered to California
and Pennsylvania on June 9 and June 11, respectively.
Biden said on Wednesday he only learned of the severity of the U.S. baby
formula shortage in early April. The White House said it had been
working around the clock since February to address the problem.
[to top of second column]
|
U.S. President Joe Biden holds a meeting with White House officials
and baby formula manufacturers, as part of the U.S. response to the
ongoing baby formula shortage, in an auditorium on the White House
campus in Washington, U.S. June 1, 2022. REUTERS/Jonathan Ernst
U.S. lawmakers have criticized the
Food and Drug Administration (FDA) for not acting promptly to
address the problems that caused the recall at Abbott's Michigan
plant, which is set to reopen June 4.
The Biden administration has relaxed its import
policy and invoked the Defense Production Act to help increase
available U.S. supplies, which is still expected to take weeks. It
has also said it could use federal resources to help transport
supplies to retailers.
Two million cans of formula have been sent from the U.K., and
Australian manufacturers are also preparing to send in more product.
Thorben Nilewski of Organic Family GmbH, which makes the popular
Holle infant formulas, said in an email that the German company
applied for the FDA’s temporary approval but has not yet received
any feedback.
Many U.S. parents rely on baby formula. Fewer than half the babies
born in the United States were exclusively breast-fed through their
first three months, according to the Centers for Disease Control and
Prevention's 2020 Breastfeeding Report Card.
The agency has said the company, which has the largest U.S. market
share for infant formula, did not have a contingency plan to produce
its specialty formulas that serve as the only source of nutrition
for thousands of babies with metabolic disorders.
(Reporting by Jarrett Renshaw and Trevor Hunnicutt; Additional
writing by Susan Heavey; Editing by Leslie Adler, Chizu Nomiyama and
Aurora Ellis)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|